Clinical trial
INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive
NCT05644301 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive
- Lead sponsor
- Universiteit Antwerpen
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 21, 2023
- Completion date
- September 30, 2026
- Enrollment
- 240 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.